MedPath

海南日中天制药有限公司

Ownership
-
Established
2002-10-23
Employees
-
Market Cap
-
Website
www.hnrzt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

Topiramate Tablets

Product Name
托吡酯片
Approval Number
国药准字H20253069
Approval Date
Jan 8, 2025
NMPA

Cefdinir Capsules

Product Name
头孢地尼胶囊
Approval Number
国药准字H20243745
Approval Date
May 21, 2024
NMPA

Pravastatin Sodium Tablets

Product Name
普伐他汀钠片
Approval Number
国药准字H20234727
Approval Date
Dec 29, 2023
NMPA

Pravastatin Sodium Tablets

Product Name
普伐他汀钠片
Approval Number
国药准字H20234726
Approval Date
Dec 29, 2023
NMPA

Cefprozil Tablets

Product Name
头孢丙烯片
Approval Number
国药准字H20133342
Approval Date
Nov 8, 2023
NMPA

Cefprozil for Suspension

Product Name
头孢丙烯干混悬剂
Approval Number
国药准字H20133341
Approval Date
Nov 6, 2023
NMPA

Cefprozil for Suspension

Product Name
头孢丙烯干混悬剂
Approval Number
国药准字H20133340
Approval Date
Nov 5, 2023
NMPA

Letrozole Tablets

Product Name
来曲唑片
Approval Number
国药准字H20233901
Approval Date
Jun 30, 2023
NMPA

Cefprozil Tablets

Product Name
头孢丙烯片
Approval Number
国药准字H20163089
Approval Date
Jun 27, 2023
NMPA

Cefdinir Dispersible Tablets

Product Name
头孢地尼分散片
Approval Number
国药准字H20120082
Approval Date
Jul 11, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.